TriSalus Life Sciences Inc.

Stock Chart, Company Information, and Scan Results

$5.10(as of Sep 18, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

TriSalus Life Sciences Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$5.10
Ticker SymbolTLSI
ExchangeNasdaq
SectorHealthcare
IndustryMedical Devices
Employees102
CountyUSA
Market Cap$345.4M
EBIDTA-27.4M
10-Day Moving Average4.83
P/E Ratio-10.54
20-Day Moving Average4.93
Forward P/E Ratio0.00
50-Day Moving Average4.83
Earnings per Share-1.33
200-Day Moving Average4.80
Profit Margin-80.54%
RSI56.49
Shares Outstanding61.6M
ATR0.31
52-Week High7.95
Volume606,900
52-Week Low2.20
Most Recent Support Level4.47
Book Value6.6M
Most Recent Resistance Level4.86
P/B Ratio45.39
Upper Keltner5.63
P/S Ratio6.60
Lower Keltner4.24
Debt-to-Equity Ratio5.26
Next Earnings Date11/12/2026
Cash Surplus35.1M
Next Ex-Dividend DateUnknown

TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States. It offers Pressure-Enabled Drug Delivery (PEDD) infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial for treating locally advanced pancreatic cancer. The company is also developing nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and pancreatic cancer. It serves interventional radiologists, IR technicians, medical oncologists, nursing support, and value analysis committee staff. The company was founded in 2009 and is headquartered in Westminster, Colorado.

TriSalus Life Sciences Inc. In Our Stock Scanner

As of Sep 20, 2026
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.